Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fortis Healthcare Ltd (FORTIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10157
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fortis Healthcare Ltd (Fortis) is an integrated healthcare provider that delivers healthcare services in the Pan Asia-Pacific region. The company’s services portfolio comprises diagnostics, primary care, day care and specialty hospitals. It owns, operates, and manages a chain of multi-specialty hospitals and super-specialty centers in India. Fortis’s hospitals provide tertiary and quaternary healthcare services to patients primarily in the areas of cardiac care, orthopedics, cancer, neuro sciences, renal care, gastroenterology, renal sciences, and mother and child care, as well as kidney and liver transplants. The company also provides pharmacy items including medical consumables and drugs. It provides healthcare services in India, Dubai, Mauritius and Sri Lanka. Fortis is headquartered in Gurgaon, Haryana, India.

Fortis Healthcare Ltd (FORTIS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Avigo Capital Rumored To Invest US$4 Million In Super Religare Labs 12
Super Religare Labs To Raise US$67 Million In Private Equity Financing 13
Partnerships 14
Super Religare Labs May Form Joint Venture 14
Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15
Equity Offering 16
Super Religare Labs May File for IPO to Raise up to USD100 Million 16
Fortis Healthcare Completes Private Placement Of Shares For US$6.2 Million 17
Fortis Healthcare Completes Private Placement Of Shares For US$33 Million 18
Fortis Healthcare Completes Private Placement Of Shares For US$55 Million 19
Debt Offering 21
Fortis Healthcare Announces Public Offering Of Bonds For US$30 Million 21
Fortis Healthcare Announces Private Placement Of Bonds For US$55 Million 22
Asset Transactions 23
Fortis Healthcare To Sell Singapore’s Health Business For Upto US$150 Million 23
Acquisition 24
Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24
Concord Medical to Acquire Fortis Surgical for USD40 Million 25
Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26
Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For US$355 Million 28
Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29
Bupa Australia Acquires Dental Corporation 30
Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For US$3 Million 32
Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For US$50 Million 33
Fortis Healthcare Completes Acquisition Of Fortis International For US$665 Million 34
Fortis Healthcare Ltd – Key Competitors 36
Fortis Healthcare Ltd – Key Employees 37
Fortis Healthcare Ltd – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Joint Venture 40
Recent Developments 41
Legal and Regulatory 41
Apr 05, 2018: Fortis to take on Daiichi in case to block its Rs 3,900-crore deal with Manipal Health 41
Mar 02, 2018: Fortis to rope in external agency to investigate inter-corporate deposits 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fortis Healthcare Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avigo Capital Rumored To Invest US$4 Million In Super Religare Labs 12
Super Religare Labs To Raise US$67 Million In Private Equity Financing 13
Super Religare Labs May Form Joint Venture 14
Fortis Healthcare Enters Into Agreement With Majid Al Futtaim Healthcare To Operate Clinics 15
Super Religare Labs May File for IPO to Raise up to USD100 Million 16
Fortis Healthcare Completes Private Placement Of Shares For US$6.2 Million 17
Fortis Healthcare Completes Private Placement Of Shares For US$33 Million 18
Fortis Healthcare Completes Private Placement Of Shares For US$55 Million 19
Fortis Healthcare Announces Public Offering Of Bonds For US$30 Million 21
Fortis Healthcare Announces Private Placement Of Bonds For US$55 Million 22
Fortis Healthcare To Sell Singapore's Health Business For Upto US$150 Million 23
Yes Bank Acquires 17.31% Stake in Fortis Healthcare 24
Concord Medical to Acquire Fortis Surgical for USD40 Million 25
Netcare and Reliance Foundation May Acquire Sevenhills Healthcare 26
Bupa Completes Acquisition Of Altai Investments From Fortis Healthcare International For US$355 Million 28
Richard Chandler Completes Acquisition Of 65% Stake In Fortis Hoan My Medical From Fortis Healthcare 29
Bupa Australia Acquires Dental Corporation 30
Royal Bank of Scotland And Jupiter Asset Management Acquire Stake In Fortis Healthcare For US$3 Million 32
Fortis Healthcare Singapore Acquires 85% Stake In RadLink-Asia For US$50 Million 33
Fortis Healthcare Completes Acquisition Of Fortis International For US$665 Million 34
Fortis Healthcare Ltd, Key Competitors 36
Fortis Healthcare Ltd, Key Employees 37
Fortis Healthcare Ltd, Other Locations 38
Fortis Healthcare Ltd, Subsidiaries 39
Fortis Healthcare Ltd, Joint Venture 40

List of Figures
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fortis Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fortis Healthcare Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fortis Healthcare Ltd (FORTIS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Livescribe Inc:企業の戦略的SWOT分析
    Livescribe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Vygon SA:医療機器:M&Aディール及び事業提携情報
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. The company offers products in various specialties such as paediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive ca …
  • IB Pharmaceuticals Inc (INNT):製薬・医療:M&Aディール及び事業提携情報
    Summary IB Pharmaceuticals Inc (IB Pharmaceuticals), formerly Innovate Biopharmaceuticals Inc, is a clinical-stage biotechnology company that discovers and develops novel medicines for orphan and gastroenterological disorders. The company’s pipeline includes INN-108 intended for inflammatory bowel d …
  • UTStarcom Holdings Corp.:企業の戦略・SWOT・財務情報
    UTStarcom Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary UTStarcom Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Coor Service Management Holding AB:企業の戦略・SWOT・財務情報
    Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report Summary Coor Service Management Holding AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • Farm Credit East, ACA:企業の戦略的SWOT分析
    Farm Credit East, ACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Plains All American Pipeline LP (PAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Plains All American Pipeline LP (PAAP) is a midstream energy company. It owns and operates the transportation, storage, terminalling and marketing of crude oil and refined petroleum products. The company also carries out the storage of natural gas, and processing, transportation, fractionati …
  • CITIC Securities Company Limited:戦略・SWOT・企業財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Precision NanoSystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision NanoSystems Inc (Precision NanoSystems) is a biopharmaceutical company that provides nanotechnology solutions to manufacture nanoparticles for molecular understanding and treatment of disease. The company offers products which include nanosystems, transfection kits for primary cell …
  • Bank Alfalah Ltd:企業の戦略・SWOT・財務分析
    Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EnergySolutions LLC:企業の戦略的SWOT分析
    EnergySolutions LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Capture Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that develops and commercializes mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Gadeta BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Gadeta BV (Gadeta) is a biotechnology company, which focuses on the research and development of cellular immunotherapies for the elimination of cancer. The company’s technology platform combines alpha beta T cells engineered to express defined Gamma Delta T cell receptors (TEGs) that demonst …
  • Chesnara plc:企業の戦略・SWOT・財務情報
    Chesnara plc - Strategy, SWOT and Corporate Finance Report Summary Chesnara plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nexstar Media Group, Inc. (NXST):企業の財務・戦略的SWOT分析
    Nexstar Media Group, Inc. (NXST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Northam Platinum Limited:企業の戦略・SWOT・財務分析
    Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Northam Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆